Myotonic Dystrophy Protein Kinase Is Critical for Nuclear Envelope Integrity*

Background: Triplet repeat expansions in myotonic dystrophy reduce muscle expression of myotonic dystrophy protein kinase (DMPK). Results: DMPK localizes to the nuclear envelope, and DMPK depletion disrupts the nuclear envelope. Conclusion: DMPK is critical to maintain nuclear envelope integrity. Significance: Reduced DMPK expression in myotonic dystrophy could contribute to nuclear instability, a common mechanism of muscle wasting in muscular dystrophies. Myotonic dystrophy 1 (DM1) is a multisystemic disease caused by a triplet nucleotide repeat expansion in the 3′ untranslated region of the gene coding for myotonic dystrophy protein kinase (DMPK). DMPK is a nuclear envelope (NE) protein that promotes myogenic gene expression in skeletal myoblasts. Muscular dystrophy research has revealed the NE to be a key determinant of nuclear structure, gene regulation, and muscle function. To investigate the role of DMPK in NE stability, we analyzed DMPK expression in epithelial and myoblast cells. We found that DMPK localizes to the NE and coimmunoprecipitates with Lamin-A/C. Overexpression of DMPK in HeLa cells or C2C12 myoblasts disrupts Lamin-A/C and Lamin-B1 localization and causes nuclear fragmentation. Depletion of DMPK also disrupts NE lamina, showing that DMPK is required for NE stability. Our data demonstrate for the first time that DMPK is a critical component of the NE. These novel findings suggest that reduced DMPK may contribute to NE instability, a common mechanism of skeletal muscle wasting in muscular dystrophies.

• Publication year

  2011

• Venue

  Journal of Biological Chemistry

• Publication date

  2011-09-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.M111.241455PMID 21949239PMCID PMC3220565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression

  2008cited by this paper
• Emerin and the nuclear lamina in muscle and cardiac disease.

  2008cited by this paper
• Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy

  2008cited by this paper
• Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin.

  2008cited by this paper
• Myotonic dystrophy protein kinase is expressed in embryonic myocytes and is required for myotube formation

  2008cited by this paper
• Nuclear envelope defects in muscular dystrophy.

  2007cited by this paper
• Myotonic dystrophy: emerging mechanisms for DM1 and DM2.

  2007cited by this paper
• Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity.

  2007cited by this paper
• Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration.

  2006cited by this paper
• Myotonic dystrophy protein kinase monoclonal antibody generation from a coiled‐coil template

  2006cited by this paper
• Remodelling of the nuclear lamina and nucleoskeleton is required for skeletal muscle differentiation in vitro

  2005cited by this paper
• Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.

  2005cited by this paper
• Myotonic Dystrophy Protein Kinase Phosphorylates Phospholamban and Regulates Calcium Uptake in Cardiomyocyte Sarcoplasmic Reticulum*

  2005cited by this paper
• Sequestration of pRb by cyclin D3 causes intranuclear reorganization of lamin A/C during muscle cell differentiation.

  2005cited by this paper
• Emerin binding to Btf, a death-promoting transcriptional repressor, is disrupted by a missense mutation that causes Emery-Dreifuss muscular dystrophy.

  2004cited by this paper
• Overexpression of CUG Triplet Repeat-binding Protein, CUGBP1, in Mice Inhibits Myogenesis*

  2004cited by this paper
• Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction.

  2004cited by this paper
• Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies.

  2004cited by this paper
• The nuclear envelope and human disease.

  2004cited by this paper
• Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.

  2003cited by this paper
• Transcriptional Repressor Germ Cell-less (GCL) and Barrier to Autointegration Factor (BAF) Compete for Binding to Emerin in Vitro *

  2003cited by this paper
• Overexpression of human myotonic dystrophy protein kinase in Schizosaccharomyces pombe induces an abnormal polarized and swollen cell morphology.

  2003cited by this paper
• Transgenic mouse models for myotonic dystrophy type 1 (DM1)

  2003cited by this paper
• Myotonic dystrophy type 2

  2003cited by this paper
• A Muscleblind Knockout Model for Myotonic Dystrophy

  2003cited by this paper
• Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.

  2002cited by this paper
• Insect lipoprotein follows a transferrin-like recycling pathway that is mediated by the insect LDL receptor homologue

  2002cited by this paper
• In vivo and in vitro interaction between human transcription factor MOK2 and nuclear lamin A/C.

  2002cited by this paper
• A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies.

  2002cited by this paper
• Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts.

  2001cited by this paper
• Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.

  2001cited by this paper
• RNA CUG Repeats Sequester CUGBP1 and Alter Protein Levels and Activity of CUGBP1*

  2001cited by this paper
• Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9

  2001cited by this paper
• Distinct changes in intranuclear lamin A/C organization during myoblast differentiation.

  2001cited by this paper
• Myotonic dystrophy protein kinase domains mediate localization, oligomerization, novel catalytic activity, and autoinhibition.

  2000cited by this paper
• Loss of a-Type Lamin Expression Compromises Nuclear Envelope Integrity Leading to Muscular Dystrophy

  1999cited by this paper
• RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance.

  1997cited by this paper
• Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice

  1996cited by this paper
• Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues

  1995cited by this paper
• Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing.

  1995cited by this paper
• Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation.

  1995cited by this paper
• Complex formation between lamin A and the retinoblastoma gene product: identification of the domain on lamin A required for its interaction.

  1994cited by this paper
• Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C.

  1993cited by this paper
• Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy.

  1993cited by this paper
• Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

  1992cited by this paper
• An unstable triplet repeat in a gene related to myotonic muscular dystrophy.

  1992cited by this paper
• Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

  1992cited by this paper
• The nuclear lamin protein family in higher vertebrates. Identification of quantitatively minor lamin proteins by monoclonal antibodies.

  1986cited by this paper

• Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective

  2025cites this paper
• Nuclear Envelope Alterations in Myotonic Dystrophy Type 1 Patient-Derived Fibroblasts

  2022cites this paper
• Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin

  2021cites this paper
• Skeletal Muscle Mitochondria Dysfunction in Genetic Neuromuscular Disorders with Cardiac Phenotype

  2021cites this paper
• An overview of heart rhythm disorders and management in myotonic dystrophy type 1.

  2021cites this paper
• RNA-sequencing reveals altered skeletal muscle contraction, E3 ligases, autophagy, apoptosis, and chaperone expression in patients with critical illness myopathy

  2019cites this paper
• Molecular Mechanisms of Myotonic Dystrophy: RNA-Mediated Pathogenesis and RNA-Binding Proteins

  2018cites this paper
• Myotonic Dystrophy and Developmental Regulation of RNA Processing.

  2018cites this paper
• Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1

  2018cites this paper
• SKELETAL MUSCLE AND CIRCULATING microRNAs IN MYOTONIC DYSTROPHY TYPE 1. SDS: BIO/10

  2017cites this paper
• Toward a more personalized motor function rehabilitation in Myotonic dystrophy type 1: The role of neuroplasticity

  2017cites this paper
• Expression and fate of normal and expanded transcripts of the myotonic dystrophy type 1 locus

  2017cites this paper
• Epigenetics of the myotonic dystrophy-associated DMPK gene neighborhood

  2016cites this paper
• Altered nuclear structure in myotonic dystrophy type 1-derived fibroblasts

  2015cites this paper
• Muscle wasting in myotonic dystrophies: a model of premature aging

  2015cites this paper
• Genome Wide Identification of Aberrant Alternative Splicing Events in Myotonic Dystrophy Type 2

  2014cites this paper
• Current World Literature

  2013cites this paper
• Epigenetic modifications in trinucleotide repeat diseases.

  2013cites this paper
• AGC protein kinases: from structural mechanism of regulation to allosteric drug development for the treatment of human diseases.

  2013cites this paper
• Mendelian Forms of Structural Cardiovascular Disease

  2013cites this paper
• DMPK prevents ROS-induced cell death by assembling a HK II-Src complex on mitochondrial surface

  2012cites this paper
• Phosphorylation target site specificity for AGC kinases DMPK E and lats2

  2012cites this paper
• Myotonic Dystrophy Protein Kinase: Structure, Function and Its Possible Role in the Pathogenesis of Myotonic Dystrophy Type 1

  2012cites this paper